Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-11 | 2024-09 | -0.05 | N/A | N/A | N/A |
2024-08-12 | 2024-06 | -0.05 | -0.05 | N/A | N/A |
2024-05-13 | 2024-03 | -0.07 | -0.05 | 0.02 | 28.57% |
2024-04-01 | 2023-12 | -0.05 | -0.06 | -0.01 | -20.00% |
2023-11-13 | 2023-09 | 0 | -0.05 | N/A | N/A |
2023-08-14 | 2023-06 | 0 | -0.06 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-07 | Cantor Fitzgerald | Upgrade | Overweight | |
2020-09-16 | Ascendiant Capital | Upgrade | Buy | |
2019-12-17 | Maxim Group | Upgrade | Hold | Buy |
2018-01-25 | Maxim Group | Upgrade | Buy | |
2013-10-06 | Sidoti & Co. | Downgrade | Buy | Neutral |
2013-04-14 | Sidoti & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2016-03-08 | CHEN SHU-CHIH | Director and Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2013-05-14 | CROSS ALEXANDER DENNIS | Director | 0.00 | Purchase |
2024-04-09 | FINN JONATHAN F. | Director | 25.00K | Purchase |
2017-11-14 | GUSE KYLE | General Counsel | 10.00K | Purchase |
2016-03-08 | QUAY STEVEN C | Chief Executive Officer | 0.00 | Purchase |
2017-04-16 | REMMEL H LAWRENCE | Director | 3.13K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 5.68M | 7.15M | 4.51% |
2023-06-29 | Blackrock Inc. | 2.90M | 3.65M | 2.30% |
2023-06-29 | Laurion Capital Management, LP | 2.23M | 2.80M | 1.77% |
2023-06-29 | Geode Capital Management, LLC | 1.11M | 1.40M | 0.88% |
2023-06-29 | Renaissance Technologies, LLC | 1.07M | 1.35M | 0.85% |
2023-06-29 | State Street Corporation | 436.27K | 549.70K | 0.35% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 3.78M | 4.76M | 3.00% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.66M | 2.10M | 1.32% |
2023-05-30 | Fidelity Extended Market Index Fund | 659.95K | 613.75K | 0.52% |
2023-05-30 | BlackRock Advantage Small Cap Core Fund | 340.50K | 316.67K | 0.27% |
2023-05-30 | Fidelity Total Market Index Fund | 182.91K | 170.11K | 0.15% |
2023-05-30 | Fidelity Series Total Market Index Fund | 142.17K | 132.22K | 0.11% |
Split | Date |
---|---|
1 : 12 | 2018-04-20 |
1 : 15 | 2016-08-26 |
-
Let’s hope he doesn’t get harsh pushback from members of Congress. Realize he is going against the narrative that many of them have clung to. Don’t be surprised if a few don’t try to spin it as “Asian hate”. Especially Democrats.
-
Daytraders dream stock here. Every day .15 cent swings. 10k shares nets you $1500 every single time. No Brainer to just keep taking the easy profits every day and hold some shares back in case of news dropping. Of course you’ll have to hear the “pApEr hANdS” cries from the fake Longs, but who gives a crap when you are actually pocketing money every day instead of waiting on this clown show of a management team to release something.
-
Lol dayum I knew I shoulda just kept daytrading this instead of playing those $7 options.
-
Finally took my brother-in-law advice and sold half of my shares at open and played the dip. 5000 shares at 3.25 and bought them back at 3.17. Quick $400. First money I’ve made in weeks since I put everything I had into this.
-
If he can work in the Covid Nasal Spray into the discussion it will be parabolic. Free press either way
-
That makes no sense. You apparently have no clue how shorting works. Why would they willingly sustain big losses like that, when they could simply cover now and then take up a Long position?
-
Some CEOs just aren’t good at managing the PR aspect of business.
-
Now you know why I normally swing 16k shares and hold 10k to the side on this. Notoriously bad management. Easier to swing and make money than waiting on them to finish the deal. A Buyout would be the ideal thing to happen here, get it into more capable hands.
-
That BDTX does look enticing. Good option plays on it as well...
-
Somebody engage Quay on Twitter concerning the Covid Wuhan conspiracy and sneak a request for trial updates in there
-
Maybe we are taking the long way around.
-
Thought we were “burning shorts” and to the moon today?
-
Kinda wish i hadn’t sold those covered calls, coulda been swinging this instead. They never release PR, easy money to make on these dips.
-
PR has been due for months now. This stock price could be over $5 and garnering way more institutional investors had it been properly managed.
-
Imagine if this company had a clue on how their stock would runup if they just released some PR now and again. If Quay just squeezed in one business related Tweet in between his conspiracy Covid rants.
-
We are at 1.7 million volume, not 9 million. It’s right there for you to easily see
-
I don’t think most of y’all even know what a squeeze is.
-
Stagnant asf.
-
This company seriously gives zero fucks about its retail investors.
-
This company never releases PR
-
Atos: contract to reinforce a supercomputer in Sweden
news.google.com • -
Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
globenewswire.com • -
3 Dirt-Cheap Drug Developers With Blockbuster Potential
investorplace.com • -
3 Penny Stock Moonshots with 300%+ Upside Potential by 2025
investorplace.com • -
Atossa Therapeutics names Heather Rees as CFO
proactiveinvestors.com • -
Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer
globenewswire.com • -
Atossa Set to Join Russell 3000® Index Effective June 28, 2024
globenewswire.com • -
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
investorplace.com • -
Atossa to Present at the Sidoti Small-Cap Investor Conference
globenewswire.com •